GWP GW Pharm.

TIDMGWP

RNS Number : 4820E

GW Pharmaceuticals PLC

10 May 2013

 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 
-------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or the underlying              GW Pharmaceuticals PLC 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: (ii) 
--------------------------------------------------  ---------------------------------- 
 2 Reason for the notification (please tick the appropriate box or boxes): 
-------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
-----------------------------------------------------------------------------  ------- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
-----------------------------------------------------------------------------  ------- 
 An acquisition or disposal of instruments with similar economic                  x 
  effect to qualifying financial instruments 
-----------------------------------------------------------------------------  ------- 
 An event changing the breakdown of voting rights 
-----------------------------------------------------------------------------  ------- 
 Other (please        Change of custodian 
  specify): 
-------------------  --------------------------------------------------------  ------- 
 3. Full name of person(s) subject                Farallon Capital Management L.L.C 
  to the 
  notification obligation: (iii) 
--------------------------------------------  ---------------------------------------- 
 4. Full name of shareholder(s)                                  N/A 
  (if different from 3.):(iv) 
--------------------------------------------  ---------------------------------------- 
 5. Date of the transaction and date                         7 May 2013 
  on 
  which the threshold is crossed 
  or 
  reached: (v) 
--------------------------------------------  ---------------------------------------- 
 6. Date on which issuer notified:                           9 May 2013 
--------------------------------------------  ---------------------------------------- 
 7. Threshold(s) that is/are crossed 
  or 
  reached: (vi, vii)                                             5% 
--------------------------------------------  ---------------------------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------------- 
 Class/type    Situation previous                             Resulting situation after the triggering 
 of             to the triggering                              transaction 
 shares         transaction 
 
 if possible 
 using 
 the ISIN 
 CODE 
------------  ---------------------------------------------  --------------------------------------------------------------- 
               Number             Number                      Number     Number of voting         % of voting rights 
                of                 of                         of          rights                   (x) 
                Shares             Voting                     shares 
                                   Rights 
------------  -----------------  --------------------------  ---------  -----------------------  --------------------------- 
                                                              Direct     Direct        Indirect   Direct         Indirect 
                                                                          (xi)          (xii) 
------------  ---  ----  ------      -------  ------  -----  ---------  ------------  ---------  -------------  ------------ 
 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------------- 
 Type of financial        Expiration           Exercise/                       Number of voting            % of voting 
  instrument               date (xiii)          Conversion Period               rights that may             rights 
                                                (xiv)                           be 
                                                                                acquired if the 
                                                                                instrument is 
                                                                                exercised/ converted. 
-----------------------  -------------------  ------------------------------  --------------------------  ------------------ 
 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------------- 
 Type of            Exercise          Expiration       Exercise/         Number of voting             % of voting rights 
 financial           price             date (xvii)      Conversion        rights instrument            (xix, xx) 
 instrument                                             period            refers to 
                                                        (xviii) 
-----------------  ----------------  ---------------  ----------------  ---------------------------  ----------------------- 
     American                                                                                         Nominal     Delta 
    depository 
     receipts 
   US36197T1034 
-----------------  ----------------  ---------------  ----------------  ----                         ----------  ----------- 
                                                                                  6720000                           5.04% 
         -------------------------------------------------------------  ---------------------------  ----------  ----------- 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                                                Percentage of voting rights 
---------------------------------------------------------------------  ----------------------------------------------------- 
 6720000                                                                5.04% 
---------------------------------------------------------------------  ----------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: (xxi) 
-------------------------------------------------------------------------------------- 
 
 
 Proxy Voting: 
-------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
-----------------------------------------------------  ------------------------------- 
 11. Number of voting rights proxy holder will 
  cease 
  to hold: 
-----------------------------------------------------  ------------------------------- 
 12. Date on which proxy holder will cease to 
  hold 
  voting rights: 
-----------------------------------------------------  ------------------------------- 
 
                                           The underlying shares to which the 
  13. Additional information:               ADRs described in section 8. C relate 
                                            have yet to be admitted to trading 
                                            on AIM. Consequently, the ADRs are 
                                            (pending the shares' admission to 
                                            trading) financial instruments with 
                                            similar economic effect to a qualifying 
                                            instrument rather than qualifying 
                                            financial instruments. When the shares 
                                            are admitted to trading they will 
                                            become qualifying financial instruments. 
----------------------------------------  -------------------------------------------- 
 14. Contact name:                         Elizabeth Wallace 
----------------------------------------  -------------------------------------------- 
 15. Contact telephone number:             +1 415 421 2132 
----------------------------------------  -------------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEASSEFADDEFF

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024